ENDPOINTS

Former a16z biotech investment leader Vijay Pande exits the VC firm

Vijay Pande is leaving Andreessen Horowitz after 11 years at the VC firm, he wrote in Monday evening posts on LinkedIn and X. His departure comes six months after he was ...

Jun 10, 2025 - 13:40
 0
Former a16z biotech investment leader Vijay Pande exits the VC firm
Vijay Pande is leaving Andreessen Horowitz after 11 years at the VC firm, he wrote in Monday evening posts on LinkedIn and X. His departure comes six months after he was ...
Read More

Tags:

Previous Article

Exclusive: Post-Lilly deal, Scorpion crew carries on with $177M at Antares

Next Article

Battle to eradicate invasive pythons in Florida achieves stunning milestone

Related Posts

Novo Nordisk plans Phase 3 trials of oral, injectable amycretin

Novo Nordisk plans Phase 3 trials of oral, injectable a...

Jun 12, 2025  0

#ASCO25: BioNTech presents impressive early data for PD-L1xVEGF in mesothelioma

#ASCO25: BioNTech presents impressive early data for PD...

Jun 3, 2025  0

Kelun's $250M PIPE; Valneva moves chikungunya vaccine to Phase 3 for kids

Kelun's $250M PIPE; Valneva moves chikungunya vaccine t...

Jun 6, 2025  0